Skip to main content
All lobbying filings

FEDERAL HEALTH COUNSEL, LLC

Lobbying for AMGEN, INC. · Pharmaceutical Company

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 26, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia

Official filing document

 Lobbying activity 1
Medicare/Medicaid

Issues related to the implementation of the Medicare Drug Negotiations and the calculation of the Medicaid Rebate and Best Price. issues relating to MFN pricing and other price controls in drugs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem